跳至主要内容
临床试验/CTRI/2025/08/092223
CTRI/2025/08/092223尚未招募不适用

Diagnostic Performance of Novel OSDx Device, OSA Plus System, and Clinical Expert in the Evaluation of Dry Eye Disease

Remidio Innovative Solutions Pvt Ltd1 个研究点 分布在 1 个国家目标入组 220 人开始时间: 2025年8月19日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
220
试验地点
1
主要终点
Definition: Diagnostic accuracy of OSDx compared to Clinical expert and predicate device (OSA plus)

研究概览

简要总结

This study aims to evaluate the diagnostic accuracy and reliability of a novel device called OSDx in the assessment of Dry Eye Disease. The performance of OSDx will be compared with a predicate device, OSA Plus, and with the clinical diagnosis made by an expert ophthalmologist. Parameters such as tear meniscus height, meibomian gland loss percentage, blink rate, and lipid layer thickness will be analyzed. Sensitivity, specificity, predictive values, and agreement among diagnostic methods will be assessed. Repeat testing in a subset of participants will be performed to evaluate intra and inter observer repeatability. All assessments will be conducted during a single clinic visit, with follow-up testing for reliability in a small subset within seven days.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Normals and dry eye subjects (based on OSDI score).

排除标准

  • Subjects who are pregnant and nursing Subjects with recent eye surgery or trauma Individuals with uncontrolled systemic diseases such as diabetes autoimmune disorders or Sjogrens syndrome which can contribute to dry eye Subject with ocular diseases such as Glaucoma Diabetic Retinopathy Cataract ARMD Uveitis infections and inflammation Subjects undertaking medication like Antihistamines Beta-blockers Antidepressants or other Glaucoma medications for example prostaglandin analogs which may affect tear film structure or quality.

结局指标

主要结局

Definition: Diagnostic accuracy of OSDx compared to Clinical expert and predicate device (OSA plus)

时间窗: At the time of a single clinical visit (Day 0); repeat testing in 20% of participants within 1–7 days to assess test–retest reliability

Measurement: Sensitivity, specificity, positive and negative predictive values

时间窗: At the time of a single clinical visit (Day 0); repeat testing in 20% of participants within 1–7 days to assess test–retest reliability

次要结局

  • Correlation of OSDx & predicate device parameters (TMH, MG loss %, blink rate analysis, & Lipid Layer Thickness).(Differences in diagnostic parameters between OSDx & predicate device (e.g., mean TM ROC, MGD, etc.).)

研究者

发起方
Remidio Innovative Solutions Pvt Ltd
申办方类型
Other [Medical Equipment Manufacturer]
责任方
Principal Investigator
主要研究者

Dr Virender Singh Sangwan

Dr Shroffs Charity Eye Hospital

研究点 (1)

Loading locations...

相似试验